UNSPSC 51453105: Morantel tartrate

This classification denotes an antihelminthic agent with the molecular formula C12H16N2S.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5WF7E9QC3F. The term morantel tartrate is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule morantel tartrate under HS 29349990 and SITC 51579. As of Q4 2014, MORANTEL TARTRATE remains US FDA's Preferred Term for this commodity. Morantel tartrate bears US NLM identifiers UMLS ID C0026535 and NCI Concept Code C75222.

SMILES: CC1CCSC1/C=C/C2=NCCCN2C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51453105 Morantel tartrate is a Commodity code that nominally identifies a single antiparasitic pharmaceutical product, but recent state and local solicitations tagged with this code actually procure a much broader range of pharmaceutical, medical supply, and health-system products—including naloxone and drug deactivation systems, first-aid and emergency medical supplies, generic pharmaceuticals, and over-the-counter products. The mismatch between the code's narrow product name and the actual scope of purchases suggests this code is being used as a catch-all for pharmaceutical and medical consumables procurement across health departments, emergency services, and cooperative purchasing vehicles. State and local issuers include county health departments, city fire and rescue divisions, state health and human services agencies, and multistate cooperative purchasing alliances; the issuing bodies span health system administration, emergency response, and centralized procurement for multiple jurisdictions.

Recent activity is distributed across Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, targeting community health initiatives. The City of Tampa's Purchasing Department released an IFB on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first-aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a 5 percent bid discount reserved for certified Small Local Business Enterprises. The Texas Health and Human Services Commission posted an RFI on April 3, 2026 exploring vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP posted January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities in Minnesota and Oregon through authorized wholesalers, with awards effective July 1, 2026.